BMD-001

N/A

Report date: 2022/12/13 14:24:46
NME

Base Information

Drug NameBMD-001
Drug Alias NameBDDS:miR-485-3p ASOBMD001BMD-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionMicroRNAs inhibitorsRNA interference
TargetsMicroRNAs
Therapy Area/IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiorchestra Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiorchestra Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A